Brain Morphometric Abnormalities in Geriatric Depression: Long-Term Neurobiological Effects of Illness Duration

The depressed subjects included in the study met DSM-IV criteria for current major depression and were enrolled in the Mental Health Intervention Research Center for Late-Life Mood Disorders (for details, see reference 10). Seventy-four of these patients had volumetric magnetic resonance imaging (MRI) scans at study entry. Thirty of these patients, who were equivalent in age and gender to our nondepressed comparison subjects, met the inclusion criterion of having no history of neurological disorder, untreated diabetes or hypertension, another axis I psychiatric disorder, substance abuse, or dementia. All of the patients included in the study had a Mini-Mental State Examination (MMSE) (11) score greater than 25 and a Mattis Dementia Rating Scale (12) score greater than 130. Volumetric MRI scans were also obtained from 47 nondepressed comparison subjects (for details of examinations and exclusion/inclusion criteria, see references 13–15). Written informed consent was obtained from all participating subjects after complete description of the study.

All subjects underwent a volumetric spoiled gradient recalled MRI sequence with a 1.5-T Signa scanner (GE Medical Systems, Madison, Wis.), yielding 120 contiguous coronal images. The normalized, segmented, and smoothed (8-mm isotropic Gaussian kernel) data were processed by using statistical parametric mapping (SPM 99) (see reference 8). The general linear model was applied to localize brain regional differences (for height threshold, p<0.001; extent threshold=30 contiguous voxels) and was corrected for multiple comparisons; age was entered as a covariate.

There was no significant difference between the depressed and comparison subjects in terms of age (mean=69.3 years, SD=5.7, and mean=66.9 years, SD=7.3, respectively) (t=–1.51, df=75, p=0.14), gender (13 [43%] and 27 [57%] men, respectively) (χ²=1.44, N=77, p=0.23), race (29 [97%] and 42 [89%] Caucasian, respectively) (χ²=1.34, N=77, p=0.25), or MMSE score (mean=29.1, SD=1.0, and mean=29.4, SD=0.9, respectively) (t=0.87, df=75, p=0.38). The depressed patients had fewer years of education than the comparison subjects (mean=14.2 years, SD=3.1, and mean=15.7 years, SD=2.7, respectively) (t=2.33, df=75, p=0.02) and a mean of 1.8 lifetime episodes of major depression (SD=0.9, range=1–5). Depressed subjects had a mean Mattis Dementia Rating Scale (12) score of 139.4 (SD=2.7) and a mean 17-item Hamilton Depression Rating Scale (16) score of 15.6 (SD=7.1).

The depressed patients had significantly smaller gray matter volume of the right hippocampus and bilateral middle frontal gyrus than the comparison subjects (Figure 1). Depressed patients also had smaller white matter volume in the left anterior cingulate and right middle frontal gyrus.

Among the depressed patients only, on a voxel-by-voxel basis within SPM 99, we correlated the gray matter volume measure with the total number of years since the first lifetime episode of depression (using current age as covariate). The total elapsed time since the first episode ranged from 1 year (with onset at age 77) to 62 years (with onset at age 11). Two areas were identified in the right and left regions of the anterior inferior medial hippocampal gyrus, possibly including the entorhinal cortex (Figure 1). Partial correlation analyses (controlling for current age) found significant negative associations between the volumes of the right (r=–0.51, df=27, p=0.004) and left (r=–0.55, df=27, p=0.002) anterior hippocampal-entorhinal regions and years elapsed since depression onset. There was no association between anterior hippocampal-entorhinal volume and the number of depressive episodes, years of education, Hamilton depression scale score, Mattis Dementia Rating Scale score, or MMSE score.

The depressed elderly subjects had significantly smaller hippocampal and prefrontal cortex volumes than nondepressed elderly subjects. The inverse correlation between the bilateral hippocampal-entorhinal volume and years since onset of depression is consistent with a study that found total lifetime duration (measured in days) to be significantly associated with hippocampal volume bilaterally (17). Our study extends these findings by identifying the anterior inferior mesial temporal lobe as the critical region of atrophy.

The apparent differential vulnerability of the anterior hippocampus and entorhinal cortex is provocative because the entorhinal region communicates with both the amygdala and the hippocampus. Disruption of these pathways impairs olfactory, visceral, and emotional processing (18), and pathological changes of the entorhinal region are associated with several neurodegenerative diseases. Our data suggest that the entorhinal region may play an important role in illness course and may have implications for the neurobiological treatment of the disease, including the use of cholinesterase inhibitors in conjunction with antidepressant pharmacotherapy.

Limitations of this study include potential inaccuracies during the segmentation procedure resulting in erroneous assignment of brain tissue (8), between-group differences in education, and limited generalizability because of a high degree of patient selection criteria.

Nevertheless, these data add to the growing body of data concerning the neuroanatomical abnormalities associated with depression in later life, particularly in patients with more elapsed time since their first episode. Our finding that the number of years since the first episode of depression was inversely associated with mesial temporal volume supports the model that hippocampal damage occurs in response to repeated exposure to elevated cortisol levels (17). Overall, these data suggest that the region of the hippocampus is exposed to “sustained” neurobiological toxins in patients with depression, resulting in reduced cell integrity.

Received Nov. 5, 2001; revision received March 19, 2002; accepted March 21, 2002. From the Neuropsychology Research Program, Functional Imaging Research Program, Mental Health Intervention Research Center for Late-Life Mood Disorders, and the Departments of Psychiatry, Radiology, Neurology, and Psychology, University of Pittsburgh Medical Center. Address reprint requests to Dr. Bell-McGinty, Neuropsychology Research Program, Suite 830, Oxford Bldg., 3501 Forbes Ave., Pittsburgh, PA 15213. Supported in part by NIMH grants MH-52247 (Mental Health Intervention Research Center for the Study of Late-Life Mood Disorders, Dr. Reynolds, Director), MH-43832, MH-37869, MH-01210, MH-59945, MH-01684 (Career Development Award, Dr. Butters), MH-19986 (Dr. Bell-McGinty), and MH-01077 (Research Scientist Development Award, Dr. Becker); by National Institute on Aging grant AG-05133 (University of Pittsburgh’s Alzheimer Disease Research Center, S.T. DeKosky, Director); and by National Heart, Lung, and Blood Institute grant HL-57529 (Cognitive and Cerebrovascular Consequences of Hypertension, J.R. Jennings, principal investigator). The authors thank M. Zmuda and S. Bensasi for their assistance with data management.